Literature DB >> 15596196

Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both.

François A Giuliano1, Albert Leriche, Eric O Jaudinot, Anne Solesse de Gendre.   

Abstract

OBJECTIVES: To survey the presence of, and attitudes toward, erectile dysfunction (ED) among patients with hypertension and/or diabetes mellitus who sought general medical care for any reason.
METHODS: The abbreviated five-item version of the International Index of Erectile Function (IIEF-5) was used to determine the presence of ED. A patient questionnaire was used to assess attitudes about ED.
RESULTS: We surveyed 7689 patients (mean +/- SD age 58.9 +/- 9.2 years), including 6719 (87%) in a stable sexual relationship. In patients with hypertension alone (n = 3906) and diabetes alone (n = 2377), ED was reported by 2379 (61%) and 1603 (67%) and was present in 2634 (67%) and 1677 (71%), respectively, as defined by an IIEF-5 score of less than 21. The corresponding mean scores were 12.0 (+/-4.6) and 11.5 (+/-4.6) in patients with ED and 20.5 (+/-3.6) and 20.2 (+/-3.8) in those without ED. Prevalence was affected by disease characteristics and history, and the number and type of antihypertensive medications. ED was reported by 924 (78%) of 1186 patients with both diseases and was present in 917 (77%) according to the IIEF-5 score. Overall, ED was reported by 5063 patients (66%) with hypertension and/or diabetes, was present in 5391 (70%) according to the IIEF-5 score, and increased in prevalence with age. ED was fairly to very bothersome in 4027 (80%) but untreated in 3312 (65%), of whom 2278 (69%) wanted treatment. Most of those wanting treatment would have welcomed discussion with their physician (1861 [82%] of 2278), and most wanted their physician to broach the subject (1292 [69%] of 1861).
CONCLUSIONS: Our study results have shown that patients with diabetes and/or hypertension have a high prevalence of bothersome untreated ED and want their general practitioner to initiate a discussion and provide treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15596196     DOI: 10.1016/j.urology.2004.08.059

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  54 in total

1.  Mobilisation of endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats.

Authors:  Xue-Feng Qiu; Xiao-Xin Li; Yun Chen; Hao-Cheng Lin; Wen Yu; Run Wang; Yu-Tian Dai
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

2.  Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes.

Authors:  Nicola Caretta; Saula Vigili de Kreutzenberg; Umberto Valente; Gabriella Guarneri; Alberto Ferlin; Angelo Avogaro; Carlo Foresta
Journal:  Endocrine       Date:  2016-01-12       Impact factor: 3.633

Review 3.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

4.  Erectile Dysfunction and Other Sexual Activity Dysfunctions among Saudi Type 2 Diabetic Patients.

Authors:  Turki Abdullah AlMogbel
Journal:  Int J Health Sci (Qassim)       Date:  2014-10

Review 5.  Management of erectile dysfunction in hypertension: Tips and tricks.

Authors:  Margus Viigimaa; Charalambos Vlachopoulos; Antonios Lazaridis; Michael Doumas
Journal:  World J Cardiol       Date:  2014-09-26

6.  Prevalence and Severity of Erectile Dysfunction as Assessed by IIEF-5 in North Indian Type 2 Diabetic Males and Its Correlation with Variables.

Authors:  Arvind Goyal; Parminder Singh; Ashish Ahuja
Journal:  J Clin Diagn Res       Date:  2013-12-15

7.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

8.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

9.  Erectile dysfunction among hypertensive men in a rapidly developing country.

Authors:  Abdulbari Bener; Abdullah Al-Ansari; Mustafa Afifi; Prasad V Krishna
Journal:  Indian J Urol       Date:  2007-04

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.